John V Jacobs

US Patent:

7249086, Jul 24, 2007

Filed:

Jan 11, 2001

Appl. No.:

09/758967

Inventors:

Steven M. Bloom - Springfield NJ, US
Michael S. Spector - Washington DC, US
John L. Jacobs - Columbia MD, US

Assignee:

The Nasdaq Stock Market, Inc. - Rockville MD

International Classification:

G06Q 40/00

US Classification:

705 37, 705 35, 705 36, 705 38

Abstract:

A financial product is based on a first fund that is traded on a trading marketplace in a first country. The financial product is registered in the first country. The first fund has the characteristics of being based on an index of securities that are traded in a second, different country. The first fund is arbitragable with a second fund that is based on the index and which is registered in a second different country. The first fund has a creation unit basis that is substantially the same basis as a creation unit basis for the second fund. The calculation of the net asset value of the first fund occurs at essentially or exactly the same time that second country fund has its NAV calculated.

US Patent:

7680725, Mar 16, 2010

Filed:

Jul 20, 2007

Appl. No.:

11/780588

Inventors:

Steven M. Bloom - Springfield NJ, US
Michael S. Spector - Washington DC, US
John L. Jacobs - Columbia MD, US

Assignee:

The NASDAQ OMX Group, Inc. - Rockville MD

International Classification:

G06Q 40/00

US Classification:

705 37

Abstract:

A financial product is based on a first fund that is traded on a trading marketplace in a first country. The financial product is registered in the first country. The first fund has the characteristics of being based on an index of securities that are traded in a second, different country. The first fund is arbitragable with a second fund that is based on the index and which is registered in a second different country. The first fund has a creation unit basis that is substantially the same basis as a creation unit basis for the second fund. The calculation of the net asset value of the first fund occurs at essentially or exactly the same time that second country fund has its NAV calculated.

US Patent:

7809627, Oct 5, 2010

Filed:

Feb 15, 2002

Appl. No.:

10/077182

Inventors:

Steven M. Bloom - Springfield NJ, US
Michael S. Spector - Washington DC, US
John L Jacobs - Columbia MD, US

Assignee:

The Nasdaq OMX Group, Inc. - Rockville MD

International Classification:

G06Q 40/00

US Classification:

705 37

Abstract:

A financial product is based on a first fund that is traded on a trading marketplace in a first country. The financial product is registered in the first country. The first fund has the characteristics of being based on an index of securities that are traded in a second, different country. The first fund is arbitragable with a second fund that is based on the index and which is registered in a second different country. The first fund has a creation unit basis that is substantially the same basis as a creation unit basis for the second fund. The calculation of the net asset value of the first fund occurs at essentially or exactly the same time that second country fund has its NAV calculated. The agent for the first fund has the option of providing or accepting second fund shares or other securities, rather than cash, to cover “cash amount” obligations. Such obligations arise from the need to equate the value received or given for the first fund shares (e. g.

US Patent:

7813992, Oct 12, 2010

Filed:

Nov 14, 2001

Appl. No.:

10/001900

Inventors:

Steven M. Bloom - Springfield NJ, US
Michael S. Spector - Washington DC, US
John L. Jacobs - Columbia MD, US

Assignee:

The Nasdaq OMX Group, Inc. - Rockville MD

International Classification:

G06Q 40/00

US Classification:

705 37

Abstract:

A financial product is based on a first fund that is traded on a trading marketplace in a first country. The financial product is registered in the first country. The first fund has the characteristics of being based on an index of securities that are traded in a second, different country. The first fund is arbitragable with a second fund that is based on the index and which is registered in a second different country. The first fund has a creation unit basis that is substantially the same basis as a creation unit basis for the second fund. The calculation of the net asset value of the first fund occurs at essentially or exactly the same time that second country fund has its NAV calculated.

US Patent:

7983983, Jul 19, 2011

Filed:

Mar 16, 2010

Appl. No.:

12/724607

Inventors:

Steven M. Bloom - Springfield NJ, US
Michael S. Spector - Washington DC, US
John L. Jacobs - Columbia MD, US

Assignee:

The NASDAQ OMX Group, Inc. - Rockville MD

International Classification:

G06Q 40/00

US Classification:

705 37

Abstract:

A financial product is based on a first fund that is traded on a trading marketplace in a first country. The financial product is registered in the first country. The first fund has the characteristics of being based on an index of securities that are traded in a second, different country. The first fund is arbitragable with a second fund that is based on the index and which is registered in a second different country. The first fund has a creation unit basis that is substantially the same basis as a creation unit basis for the second fund. The calculation of the net asset value of the first fund occurs at essentially or exactly the same time that second country fund has its NAV calculated.

US Patent:

7983985, Jul 19, 2011

Filed:

Oct 5, 2010

Appl. No.:

12/897856

Inventors:

Steven M. Bloom - Springfield NJ, US
Michael S. Spector - Washington DC, US
John L. Jacobs - Columbia MD, US

Assignee:

The NASDAQ OMX Group, Inc. - Rockville MD

International Classification:

G06Q 40/00

US Classification:

705 37, 705 36 R

Abstract:

A financial product is based on a first fund that is traded on a trading marketplace in a first country. The financial product is registered in the first country. The first fund has the characteristics of being based on an index of securities that are traded in a second, different country. The first fund is arbitragable with a second fund that is based on the index and which is registered in a second different country. The first fund has a creation unit basis that is substantially the same basis as a creation unit basis for the second fund. The calculation of the net asset value of the first fund occurs at essentially or exactly the same time that second country fund has its NAV calculated. The agent for the first fund has the option of providing or accepting second fund shares or other securities, rather than cash, to cover “cash amount” obligations. Such obligations arise from the need to equate the value received or given for the first fund shares (e. g.

US Patent:

20090076481, Mar 19, 2009

Filed:

Mar 24, 2008

Appl. No.:

12/076846

Inventors:

THOMAS J. STEGMANN - PETERSBERG, DE
KENNETH A. THOMAS - CHATHAM NJ, US
JOHN W. JACOBS - AMARILLO TX, US
TUGAN MUFTULER - ALISO VIEJO CA, US
SHADFAR BAHRI - IRVINE CA, US
HON YU - IRVINE CA, US
VANCE GARDNER - IRVINE CA, US

International Classification:

A61M 5/00
A61B 5/05

US Classification:

604522, 600407, 6048911

Abstract:

The invention relates to methods for the diagnosis, amelioration, and treatment of back pain, particularly lumbar back pain, in particular, back pain caused by muscular abnormalities, vertebral body osteoporosis, and disc degeneration. Patients with back pain are categorized into specific subsets that are deemed to have potential to respond to therapy. In particular, the invention includes a therapy involving stimulation of neovascularization so as to increase perfusion of various spine compartments.

US Patent:

20210212565, Jul 15, 2021

Filed:

Mar 31, 2021

Appl. No.:

17/218931

Inventors:

- Dallas TX, US
Kenneth Thomas - Chatham NJ, US
John Jacobs - Berkeley CA, US
Thomas Stegmann - Petersberg, DE
Mickael Flaa - Las Vegas NV, US
Laurence R. Meyerson - Henderson NV, US

International Classification:

A61B 5/00
A61K 38/18
A61P 9/10
G01N 21/31
G01N 21/359

Abstract:

Devices, methods, systems and procedures for localized, targeted treatment of angiogenic-based therapy in at least one region of interest in one or more layers of cardiac tissue. Various methods can include diagnosing a patient with ischemic heart disease or “at-risk” of manifesting ischemic heart disease, placing the patient into a specific angiogenic-based treatment therapy group, collecting image data, confirming image data and other diagnostic test results, developing a preoperative plan to target region of interest, inserting the catheter into a heart chamber, monitoring the distal end of the catheter tip within the heart on a visual display, contacting at least one layer of cardiac tissue, creating one or more channels in the heart tissue and/or administering the angiogenic-based therapy.